Dogwood Therapeutics Statistics
Total Valuation
DWTX has a market cap or net worth of $51.79 million. The enterprise value is $38.71 million.
| Market Cap | 51.79M |
| Enterprise Value | 38.71M |
Important Dates
The last earnings date was Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DWTX has 33.63 million shares outstanding. The number of shares has increased by 987.60% in one year.
| Current Share Class | 33.63M |
| Shares Outstanding | 33.63M |
| Shares Change (YoY) | +987.60% |
| Shares Change (QoQ) | +131.01% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 1.22% |
| Float | 5.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.86, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.86 |
| Quick Ratio | 5.17 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.67% and return on invested capital (ROIC) is -21.83%.
| Return on Equity (ROE) | -34.67% |
| Return on Assets (ROA) | -18.60% |
| Return on Invested Capital (ROIC) | -21.83% |
| Return on Capital Employed (ROCE) | -30.86% |
| Weighted Average Cost of Capital (WACC) | 13.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.54M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, DWTX has paid $31,747 in taxes.
| Income Tax | 31,747 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.98% in the last 52 weeks. The beta is 1.70, so DWTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.70 |
| 52-Week Price Change | -68.98% |
| 50-Day Moving Average | 1.62 |
| 200-Day Moving Average | 3.75 |
| Relative Strength Index (RSI) | 43.67 |
| Average Volume (20 Days) | 58,963 |
Short Selling Information
The latest short interest is 65,085, so 0.19% of the outstanding shares have been sold short.
| Short Interest | 65,085 |
| Short Previous Month | 108,418 |
| Short % of Shares Out | 0.19% |
| Short % of Float | 1.23% |
| Short Ratio (days to cover) | 0.80 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.60M |
| Pretax Income | -28.29M |
| Net Income | -28.32M |
| EBITDA | -28.61M |
| EBIT | -28.60M |
| Earnings Per Share (EPS) | -$2.18 |
Balance Sheet
The company has $13.23 million in cash and $144,930 in debt, with a net cash position of $13.08 million or $0.39 per share.
| Cash & Cash Equivalents | 13.23M |
| Total Debt | 144,930 |
| Net Cash | 13.08M |
| Net Cash Per Share | $0.39 |
| Equity (Book Value) | 80.62M |
| Book Value Per Share | 2.41 |
| Working Capital | 12.44M |
Cash Flow
| Operating Cash Flow | -15.52M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | -14,443 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DWTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -987.60% |
| Shareholder Yield | -987.60% |
| Earnings Yield | -54.68% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for DWTX is $14.00, which is 809.09% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 809.09% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 9, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Oct 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |